搜索结果：Portuguese journal of public health

No AccessWorld Development Report1 Feb 2013World Development Report 1993Investing in Health, Volume1Authors/Editors: World BankWorld Bankhttps://doi.org/10.1596/0-1952-0890-0AboutView ChaptersPDF (6.2 MB) ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinked In Abstract:This is the sixteenth in the annual series and examines the interplay between human health, health policy and economic development. Because good health increases the economic productivity of individuals and the economic growth rate of countries, investing in health is one means of accelerating development. More important, good health is a goal in itself. During the past forty years life expectancy in the developing world has risen and child mortality has decreased, sometimes dramatically. But progress is only one side of the picture. The toll from childhood and tropical diseases remains high even as new problems - including AIDS and the diseases of aging populations - appear on the scene. And all countries are struggling with the problems of controlling health expenditures and making health care accessible to the broad population. This report examines the controversial questions surrounding health care and health policy. Its findings are based in large part on innovative research, including estimation of the global burden of disease and the cost-effectiveness of interventions. These assessments can help in setting priorities for health spending. The report advocates a threefold approach to health policy for governments in developing countries and in the formerly socialist countries. First, to foster an economic environment that will enable households to improve their own health. Policies for economic growth that ensure income gains for the poor are essential. So, too, is expanded investment in schooling, particulary for girls. Second, redirect government spending away from specialized care and toward such low-cost and highly effective activities such as immunization, programs to combat micronutrient deficiencies, and control and treatment of infectious diseases. By adopting the packages of public health measures and essential clinical care dsecribed in the report, developing countries could reduce their burden of disease by 25 percent. Third, encourage greater diversity and competition in the provision of health services by decentralizing government services, promoting competitive procurement practices, fostering greater involvement by nongovernmental and other private organizations, and regulating insurance markets. These reforms could translate into longer, healthier, and more productive lives for people around the world, and especially for the more than 1 billion poor. As in previous editions, this report includes the World Development Indicators, which give comprehensive, current data on social and economic development in more than 200 countries and territories. Previous bookNext book FiguresreferencesRecommendeddetailsCited byLatin America at the margins? Implications of the geographic and epistemic narrowing of 'global' healthGlobal Public Health, Vol.19, No.126 December 2023Pay-for-performance in healthcare provision: the role of discretion in policy implementation in TurkeyInternational Journal of Public Sector Management, Vol.36, No.6/78 August 2023Questioning global health in the times of COVID-19: Re-imagining primary health care through the lens of politics of knowledgeHumanities and Social Sciences Communications, Vol.10, No.121 May 2023Cost-Effectiveness Analysis of a Regional Program for Identifying and Treating Children with Correctable Refractive Error in IndonesiaOphthalmic Epidemiology, Vol.165 October 2023Primary Health-Care Financing and Resource Mobilization8 September 2023Knowledge politics in global governance: philanthropists' knowledge-making practices in global healthReview of International Political Economy, Vol.130 August 2023From health inequalities to health justice in 50 yearsCommunity Dentistry and Oral Epidemiology, Vol.51, No.417 May 2023Cause of death certificates in nursing homes: Does quality matter? A retrospective review from two counties in NorwayScandinavian Journal of Public Health, Vol.726 July 2023Geographic Mythology and Global HealthAnnals of the American Association of Geographers, Vol.113, No.625 April 2023Women's employment trajectories in a low-income setting: Stratification and change in NepalDemographic Research, Vol.499 August 2023From Imperialism to the "Golden Age" to the Great Lockdown: The Politics of Global Health GovernanceAnnual Review of Political Science, Vol.26, No.1Examining the computation of the underlying components of DALYsHealth Policy and Planning, Vol.38, No.515 March 2023Repackaging growth at Davos: the World Economic Forum's inclusive growth and development approachReview of International Political Economy, Vol.30, No.326 May 2022NotesThe Sensible MediumMedia Theory (in a Pandemic)The Multispecies KinestheticBibliographyThe Epidemic EpistemeEpidemic MediaThe -Morphic ImageExperiences of implementing hospital management information system (HMIS) at a tertiary care hospital, IndiaVilakshan - XIMB Journal of Management, Vol.20, No.119 November 2021On the genealogy of the global health justice movementGlobal Public Health, Vol.18, No.16 December 2023Financing Development Through PPPs: What Does This Mean for Inequalities22 April 2023Definition, Principles, and Evolution of Global Health8 September 2023Uma História Global e Brasileira da Aids, 1986-20211 January 2023Unfair Wealth-Transfer Effects of the Palm Oil Trade in Nigeria 1868–1959: Illustrative Partial Estimates18 January 2024Why cost-effectiveness thresholds for global health donors differ from thresholds for Ministries of Health (and why it matters)F1000Research, Vol.1227 February 2023Understanding the Global Health ArchitectureMethodological considerations in injury burden of disease studies across Europe: a systematic literature reviewBMC Public Health, Vol.22, No.117 August 2022Out-of-pocket Health Spending and Its Impact on Household Well-being in MaharashtraJournal of Health Management, Vol.24, No.431 October 2021Reflexões sobre o resgate da economia política na análise do setor saúde no Brasil e na América Latina no século XXI22 November 2022Decolonising the global to local movement: Time for a new paradigmGlobal Public Health, Vol.17, No.1117 November 2021Time‐resolved dynamic disability adjusted life‐years estimationIndoor Air, Vol.32, No.1118 November 2022The impact of the social adaptability of different groups on the human capital level in an uncertain environment: Panel data analysis based on 35 urban life satisfactionFrontiers in Psychology, Vol.1326 October 2022Philosophy of sustainable development: understanding public healthEnvironment, Development and Sustainability, Vol.24, No.1011 November 2021Establishing political priority for global mental health: a qualitative policy analysisHealth Policy and Planning, Vol.37, No.813 June 2022IntroductionThe National University EscuelaClinical Social MedicineReligion and Caring in a Medical SettingHospital Budgets before and after NeoliberalismViolence and ResistanceRemaining amid DestructionLearning and Practicing Medicine in a For-Profit SystemFinal RemarksNotesReferencesBurden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choicesEuropean Journal of Public Health, Vol.32, No.27 January 2022Seasonal quality of water sources indicated by Escherichia coli: a case of Elobied, North Kordofan state, SudanApplied Water Science, Vol.12, No.311 February 2022The Social Construction of Global Health Priorities: An Empirical Analysis of Contagion in Bilateral Health AidInternational Studies Quarterly, Vol.66, No.121 December 2021IntroductionEmbodied Value TheoryRelative ValueNever EnoughMaking a DifferencePharmaceutical Citizenship, Marketing, and the Global Monoculture of HealthWhat Drugs Do in Different SpacesActing through Other (Prescribing) HabitsCulture, Context, and ConsensusGenericSame Ills, Same PillsFailed BiocommensurationsReferencesGlobal Sanitation Crisis: Challenges and Responses11 June 2022Epidemiology and Economics of Deworming2 August 2022Air Pollution and Health: Economic Implications13 October 2022Health29 October 2021Sustaining Development Process: Set of New Targets25 August 2022Impact of COVID-19 on Sustainable Development Goals25 August 2022Conclusion and Way Forward25 August 2022Non-Governmental Organizations as Partners for Sustainable Local Development: Ghana's Experiences15 November 2022Comprehensive Assessment of Health System Performance in Odisha, IndiaHealth Systems & Reform, Vol.8, No.119 October 2022Complex Humanitarian Emergencies: Concepts and Issues4 January 2023Predicted Effects and Cost-Effectiveness of Wheat Flour Fortification for Reducing Micronutrient Deficiencies, Maternal Anemia, and Neural Tube Defects in Yaoundé and Douala, CameroonFood and Nutrition Bulletin, Vol.42, No.45 August 2021Recruitment, training and supervision of nurses and nurse assistants for a task-shifting depression intervention in two RCTs in Brazil and PeruHuman Resources for Health, Vol.19, No.15 February 2021Good soil management can reduce dietary zinc deficiency in ZimbabweCABI Agriculture and Bioscience, Vol.2, No.126 September 2021Approaches to Defining Scientific Priorities in Healthcare and Medicine: The Experience of the Soviet UnionScientific and Technical Information Processing, Vol.48, No.617 March 2022Introducing the Adequate Housing Index (AHI): A New Approach to Estimate the Adequate Housing Deficit within and across Emerging Economies17 November 2021Convergence theory and conditional income convergence among sub‐Saharan African countriesAgricultural Economics, Vol.52, No.69 August 2021Global estimated Disability-Adjusted Life-Years (DALYs) of diarrheal diseases: A systematic analysis of data from 28 years of the global burden of disease studyPLOS ONE, Vol.16, No.1027 October 2021The 'noncommunicable disease space': ethnographies of conferences, advocacy and outrageCritical Public Health, Vol.31, No.56 July 2020Retail pharmacy prescription medicines' availability, prices and affordability in EswatiniAfrican Journal of Primary Health Care & Family Medicine, Vol.13, No.115 September 2021Do health infrastructure and services, aging, and environmental quality influence public health expenditures? Empirical evidence from PakistanSocial Work in Public Health, Vol.36, No.625 August 2021The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030PLOS Neglected Tropical Diseases, Vol.15, No.726 July 2021Valuing health outcomes: developing better defaults based on health opportunity costsExpert Review of Pharmacoeconomics & Outcomes Research, Vol.21, No.420 September 2020Making Health Insurance Pro-poor: Lessons from 20 Developing CountriesHealth Systems & Reform, Vol.7, No.217 August 2021Midwives providing maternal health services to poor women in the private sector: is it a financially feasible model?Health Policy and Planning, Vol.36, No.63 May 2021The Breathing Catastrophe: COVID-19 and Global Health GovernanceDevelopment, Vol.64, No.1-213 July 2021Filtering Inequality: Screening and Knowledge in Senegal's Topography of Hepatitis B CareFrontiers in Pharmacology, Vol.1112 April 2021The advice they give: Knowledge transfer of international organisations in countries of the former Soviet UnionGlobal Social Policy, Vol.21, No.14 December 2020How Do Metrics Shape Polities? From Analogue to Digital Measurement Regimes in International Health PoliticsInternational Political Sociology, Vol.15, No.17 September 2020Scaling Up Delivery of Biofortified Staple Food Crops Globally: Paths to Nourishing MillionsFood and Nutrition Bulletin, Vol.42, No.117 February 2021Integrated Management of Childhood Health in the Eastern Mediterranean Region11 August 2021Transforming Health Financing Systems in the Arab World Toward Universal Health Coverage11 August 2021Violence Against Women in the Arab World: Eyes Shut Wide Open11 August 2021Transforming Health Financing Systems in the Arab World Toward Universal Health Coverage10 February 2021Health Status and Economic Growth8 November 2020Necessity of Big Data Analytics in Social Media for Questioning the Existence and Survival of Women and the Marginalized People11 October 2021Review of the inclusion of SRHR interventions in essential packages of health services in low- and lower-middle income countriesSexual and Reproductive Health Matters, Vol.29, No.115 November 2021OUP accepted manuscriptThe Journal of Infectious Diseases1 January 2021United Nations and Global Health21 December 2020United Nations and Global Health12 May 2021Admission platelet count and indices as predictors of outcome in children with severe Sepsis: a prospective hospital-based studyBMC Pediatrics, Vol.20, No.119 August 2020History of global burden of disease assessment at the World Health OrganizationArchives of Public Health, Vol.78, No.124 August 2020SAĞLIK RİSK FAKTÖRLERİNE GÖRE ÜLKELERİN KÜMELENMESİ VE ÇOK KRİTERLİ KARAR VERME TEKNİKLERİYLE SAĞLIK DURUMU GÖSTERGELERİNİN ANALİZİSosyal Guvence30 November 2020Mother's Nutritional Knowledge and Practice: A study on Slum Area of Khulna CityEuropean Journal of Medical and Health Sciences, Vol.2, No.629 November 2020Is Gender-Based Violence a Social Norm? Rethinking Power in a Popular Development InterventionFeminist Review, Vol.126, No.122 October 2020Global Common Goods for Health: Towards a New Framework for Global FinancingGlobal Policy, Vol.11, No.522 November 2020The Devils in the DALY: Prevailing Evaluative AssumptionsPublic Health Ethics, Vol.1629 October 2020Falls in older aged adults in 22 European countries: incidence, mortality and burden of disease from 1990 to 2017Injury Prevention, Vol.26, No.Suppl 228 February 2020An Accidental NutritionistAnnual Review of Nutrition, Vol.40, No.1What Happened to the Global Forum for Health Research?Global Public Health, Vol.15, No.815 April 2020Estimating the Health and Economic Benefits of Universal Salt Iodization Programs to Correct Iodine Deficiency DisordersThyroid17 July 2020Incidence and Trends of Breast and Cervical Cancers: A Joinpoint Regression AnalysisIndian Journal of Medical and Paediatric Oncology, Vol.41, No.0517 May 2021Mapping crimes against women: spatio-temporal analysis of braid chopping incidents in Kashmir Valley, IndiaGeoJournal, Vol.85, No.213 February 2019Eliciting and Utilizing Willingness to Pay: Evidence from Field Trials in Northern GhanaJournal of Political Economy, Vol.128, No.4The strengths and limitations of using hospital records to assess environmental health in Karonga, MalawiEnvironment and Urbanization, Vol.32, No.118 July 2019African Conceptions of Age‐Based Moral Standing: Anchoring Values to Regional RealitiesHastings Center Report, Vol.50, No.220 April 2020If You Build It Nearby and Keep the Price Low, Will They Come? Large‐Scale Evidence on the Relative Roles of Access and Quality in Use of Healthcare in Low‐and Middle‐Income CountriesSouth African Journal of Economics, Vol.88, No.13 February 2020Limited alignment of publicly competitive disease funding with disease burden in JapanPLOS ONE, Vol.15, No.210 February 2020Using mHealth to improve health care delivery in India: A qualitative examination of the perspectives of community health workers and beneficiariesPLOS ONE, Vol.15, No.115 January 2020Disability-Adjusted Life Years (DALYs)20 October 2020The Path for Introducing Diagnosis Related Groups (DRGs) in Albanian Health care28 April 2020Inter-Sectoral Allocation Choices3 November 2020Health Status and Economic Growth1 June 2020Service and Knowledge: The Emergence of Disability Studies Extension3 April 2020Alternative Destinies and Solidarities for Health and Medicine in Latin America Before and During the Cold WarUnder SurveillanceNational Politics and Scientific PursuitsCold War Mexico in a Time of "Wonder Drugs"The Puerto Rico Family Life Study and the Cold War Politics of Fertility SurveysParasitology and CommunismRevolutionizing Cuban PsychiatryFrom Cold War Pressures to State Policy to People's Health"Psychotherapy of the Oppressed"South-South Cooperation as a Cold War TonicA Lingering Cold (War)?BibliographyTraffic in Asian WomenAsian Women as Method?Traffic in WomenSexual SlaveryViolence against WomenTruth DisclosureJust CompensationEnduring MemorialsNotesBibliographyVom Sehen zum Leben – die Stiftung Sight and Life7 August 2020From Washington DC to Washington State: The Global Burden of Diseases Data Basis and the Political Economy of Global Health30 June 2020Gaps and barriers in interventions for the control of soil-transmitted helminthiasis among school-age children in an endemic area of the Philippines: a school-based point-of-viewJournal of Public Health Policy, Vol.40, No.47 August 2019Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in AfricaInfectious Diseases of Poverty, Vol.8, No.14 July 2019Into the Machine: Economic Tools, Sovereignty, and Joy in a Global Health InstitutionMedical Anthropology Quarterly, Vol.33, No.416 July 2019A Review of Economic Consequences and Costs of Male Violence Against WomenIndian Journal of Gender Studies, Vol.26, No.324 October 2019Projecting burden of hypertension and its management in Turkey, 2015-2030PLOS ONE, Vol.14, No.911 September 2019Can Basic Maternal Literacy Skills Improve Infant Health Outcomes? Evidence from the Education Act in NepalJournal of Human Capital, Vol.13, No.3Deconstructing the Financialization of HealthcareDevelopment and Change, Vol.50, No.56 June 2019What Explains Uneven Female Labor Force Participation Levels and Trends in Developing Countries?World Bank Research Observer, Vol.34, No.210 September 2019Effectiveness, Cost-Effectiveness, and Economic Impact of a Multi-Specialty Charitable Surgical Center in HondurasInternational Journal of Surgery OpenChallenges in the implementation of primary health care reforms: a qualitative analysis of stakeholders' views in TurkeyBMJ Open, Vol.9, No.719 July 2019Regional Disparities in Social Development: Evidence from States and Union Territories of IndiaSouth Asian Survey, Vol.26, No.123 April 2019Integrated Management of Childhood Health in the Eastern Mediterranean Region14 March 2019Violence Against Women in the Arab World: Eyes Shut Wide Open5 June 2019A semi-endogenous growth with public capital and for developing of Economics, Vol.22, June of Economic Studies, of Vol.33, Global Burden of to From Journal of Public Health, National Burden of from Evidence to of Medical Science, Vol.34, No.Suppl January of rate on and services Evidence from a large Journal of International Trade & Economic December after Primary Health Care and Health for to Global Health, No.Suppl December the quality of life of women: a systematic reviewBMC and Vol.18, No.123 November of of death on child in a African Public Health, Vol.18, No.16 November health for all to health is and Health, Vol.14, No.13 July of a systematic review and & Vol.11, February can improve priority and Resource Vol.16, November and in and and health and Public Health, Vol.13, November the of the global burden of disease for and for low- and Research, of diseases in low-income to countries international Global Health, October of the of in the Journal of & Vol.29, June global and the of for and and Vol.38, No.45 October politics and of a of of Vol.29, March from an health information system implementation in No.56 August Health Status of in Research, No.121 August of disease studies in the European Journal of Public Health, April in with at a Research, Vol.40, No.726 March against the economic growth and in Studies, Vol.14, April of in India: An International Journal of Health and Management, Vol.33, No.220 October Policy and March development and health in the Journal of Social Economics, in Health: A of and Economic No.15 March of death in the global burden of of Medical Ethics, October mortality to in a assessment by Open, Vol.8, February Allocation for in the National Health An Analysis of the of Health Policy and Violence and October World August and the Value of December October Healthcare Policy from to November Public Health, Vol.13, of with for control in a and cost-effectiveness study Global Health, January National Burden of from Evidence to of Medical Science, Vol.33, January health and through in Research, September Health and for January for Public Health January Global Health: A analysis of a Vol.12, June and barriers to evidence based in the health system in of health Health Research, Vol.17, February health and a case study of of in Journal for in Health, Vol.16, No.115 September disability for a Health Vol.15, No.14 March of human lives due to tropical diseases in AfricaInfectious Diseases of Poverty, No.118 December of and global health to Sustainable Development in Health Vol.10, May and Health and Development: Neglected December Infectious from Control December December 2017Injury and Health: from Control December and of maternal and care economic analysisHealth Policy and Planning, Vol.32, October Political in Health Delivery in Journal of Health August Organizations in to Healthcare Access for the and in and Sector Quarterly, June of a intervention to the system in Public Health, Vol.12, February Journal of Development Studies Vol.38, April for Health from the Relative Social Vol.37, July of in and Vol.21, November and The Experience of Women in Journal of Gender Studies, Vol.24, February and treatment of mental in primary of a systematic review and of the New of Sciences, October Health Systems in Eastern and North African CountriesHealth Systems & Reform, January Health and in November of and November for to as The of Economic in the from International to Global Health March Organizations and to March February Policy and Planning, Vol.32, and between health and global health why a Global Health, Vol.2, January Health in the and of Economic The of and the of Public Health Evidence from and impact of human development on health: a analysis through and March of priority setting in health and health No.16 October Cost-Effectiveness, and January the of of of A During Health in and Nutrition Bulletin, Vol.37, No.420 September of global mental December for health: an study with case studies from Public Health, Vol.16, September priority setting for health challenges in of health Medicine, Vol.14, May system and health system two to the implementation of treatment in Economics Review, July health in a healthcare Medicine & International Health, Vol.21, August and global health: human and Public Health, Vol.26, June disease burden in countries: a using the Global Burden of and June and in of International Economics and Policy, September and Health: The and the Vol.10, October Knowledge in A for a Health Vol.13, May and burden of

BACKGROUND: The increasing involvement of pharmacists in public health will require changes in the behaviour of both pharmacists and the general public. A great deal of research has shown that attitudes and beliefs are important determinants of behaviour. This review aims to examine the beliefs and attitudes of pharmacists and consumers towards pharmaceutical public health in order to inform how best to support and improve this service. METHODS: Five electronic databases were searched for articles published in English between 2001 and 2010. Titles and abstracts were screened by one researcher according to the inclusion criteria. Papers were included if they assessed pharmacy staff or consumer attitudes towards pharmaceutical public health. Full papers identified for inclusion were assessed by a second researcher and data were extracted by one researcher. RESULTS: From the 5628 papers identified, 63 studies in 67 papers were included. Pharmacy staff: Most pharmacists viewed public health services as important and part of their role but secondary to medicine related roles. Pharmacists' confidence in providing public health services was on the whole average to low. Time was consistently identified as a barrier to providing public health services. Lack of an adequate counselling space, lack of demand and expectation of a negative reaction from customers were also reported by some pharmacists as barriers. A need for further training was identified in relation to a number of public health services. Consumers: Most pharmacy users had never been offered public health services by their pharmacist and did not expect to be offered. Consumers viewed pharmacists as appropriate providers of public health advice but had mixed views on the pharmacists' ability to do this. Satisfaction was found to be high in those that had experienced pharmaceutical public health CONCLUSIONS: There has been little change in customer and pharmacist attitudes since reviews conducted nearly 10 years previously. In order to improve the public health services provided in community pharmacy, training must aim to increase pharmacists' confidence in providing these services. Confident, well trained pharmacists should be able to offer public health service more proactively which is likely to have a positive impact on customer attitudes and health.

BACKGROUND: There is increasing recognition that the development of evidence-informed health policy is not only a technical problem of knowledge exchange or translation, but also a political challenge. Yet, while political scientists have long considered the nature of political systems, the role of institutional structures, and the political contestation of policy issues as central to understanding policy decisions, these issues remain largely unexplored by scholars of evidence-informed policy making. METHODS: We conducted a systematic review of empirical studies that examined the influence of key features of political systems and institutional mechanisms on evidence use, and contextual factors that may contribute to the politicisation of health evidence. Eligible studies were identified through searches of seven health and social sciences databases, websites of relevant organisations, the British Library database, and manual searches of academic journals. Relevant findings were extracted using a uniform data extraction tool and synthesised by narrative review. FINDINGS: 56 studies were selected for inclusion. Relevant political and institutional aspects affecting the use of health evidence included the level of state centralisation and democratisation, the influence of external donors and organisations, the organisation and function of bureaucracies, and the framing of evidence in relation to social norms and values. However, our understanding of such influences remains piecemeal given the limited number of empirical analyses on this subject, the paucity of comparative works, and the limited consideration of political and institutional theory in these studies. CONCLUSIONS: This review highlights the need for a more explicit engagement with the political and institutional factors affecting the use of health evidence in decision-making. A more nuanced understanding of evidence use in health policy making requires both additional empirical studies of evidence use, and an engagement with theories and approaches beyond the current remit of public health or knowledge utilisation studies.

BACKGROUND: As digitalization is progressively permeating all aspects of society, how can be it fruitfully employed to sustain the public health goals of quality, accessibility, efficiency and equity in health care and prevention? In this paper, we reflect on the potential of applying digital tools to public health and discuss some key challenges. METHODS: We first define 'digitalization' in its broader sense, as well as applied to public health. We then build a conceptual framework where key public health domains are associated to available digital technologies in a matrix that help to identify digital features that bolster public health action. We also provide illustrative data and evidence on the application of digital solutions on selected public health areas. In the second part, we identify the strategic pillars for a successful European strategy for public health digitalization and we outline how the approach being pursued by the European Public Health Association (EUPHA) applies to digital health. RESULTS: From a public health perspective, digitalization is being touted as providing several potential benefits and advantages, including support for the transition from cure to prevention, helping to put people and patients at the center of care delivery, supporting patient empowerment and making healthcare system more efficient, safer and cheaper. These benefits are enabled through the following features of digital technologies: (i) Personalization and precision; (ii) Automation; (iii) Prediction; (iv) Data analytics and (v) Interaction. CONCLUSION: A successful European strategy for public health digitalization should integrate the following pillars: political commitment, normative frameworks, technical infrastructure, targeted economic investments, education, research, monitoring and evaluation. EUPHA acknowledges digitalization is an asset for public health and is working both to promote the culture of "public health digitalization", as well as to enable its planning, implementation and evaluation at the research, practice and policy level.

It is well known that papers written in languages other than English have a great risk of being ignored simply because these languages are not accessible to the international scientific community. The objective of this paper is to facilitate the access to the public health and epidemiology literature available in Portuguese speaking countries. It was found that it is particularly concentrated in Brazil, with some few examples in Portugal and none in other Portuguese speaking countries. This literature is predominantly written in Portuguese, but also in other languages such as English or Spanish. The paper describes the several journals, as well as the bibliographic databases that index these journals and how to access them. Most journals provide open-access with direct links in the indexing databases. The importance of this scientific production for the development of epidemiology as a scientific discipline and as a basic discipline for public health practice is discussed. To marginalize these publications has implications for a more balanced knowledge and understanding of the health problems and their determinants at a world-wide level.

BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. METHODS: GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk-outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk-outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk-outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden. FINDINGS: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10·8 million (95% uncertainty interval [UI] 9·51-12·1) deaths (19·2% [16·9-21·3] of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8·71 million (8·12-9·31) deaths (15·4% [14·6-16·2] of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253-350) DALYs (11·6% [10·3-13·1] of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0-9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10-24 years, alcohol use for those aged 25-49 years, and high systolic blood pressure for those aged 50-74 years and 75 years and older. INTERPRETATION: Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. FUNDING: Bill & Melinda Gates Foundation.

BACKGROUND: Educational outreach visits (EOVs) have been identified as an intervention that may improve the practice of healthcare professionals. This type of face-to-face visit has been referred to as university-based educational detailing, academic detailing, and educational visiting. OBJECTIVES: To assess the effects of EOVs on health professional practice or patient outcomes. SEARCH STRATEGY: For this update, we searched the Cochrane EPOC register to March 2007. In the original review, we searched multiple bibliographic databases including MEDLINE and CINAHL. SELECTION CRITERIA: Randomised trials of EOVs that reported an objective measure of professional performance or healthcare outcomes. An EOV was defined as a personal visit by a trained person to healthcare professionals in their own settings. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data and assessed study quality. We used bubble plots and box plots to visually inspect the data. We conducted both quantitative and qualitative analyses. We used meta-regression to examine potential sources of heterogeneity determined a priori. We hypothesised eight factors to explain variation across effect estimates. In our primary visual and statistical analyses, we included only studies with dichotomous outcomes, with baseline data and with low or moderate risk of bias, in which the intervention included an EOV and was compared to no intervention. MAIN RESULTS: We included 69 studies involving more than 15,000 health professionals. Twenty-eight studies (34 comparisons) contributed to the calculation of the median and interquartile range for the main comparison. The median adjusted risk difference (RD) in compliance with desired practice was 5.6% (interquartile range 3.0% to 9.0%). The adjusted RDs were highly consistent for prescribing (median 4.8%, interquartile range 3.0% to 6.5% for 17 comparisons), but varied for other types of professional performance (median 6.0%, interquartile range 3.6% to 16.0% for 17 comparisons). Meta-regression was limited by the large number of potential explanatory factors (eight) with only 31 comparisons, and did not provide any compelling explanations for the observed variation in adjusted RDs. There were 18 comparisons with continuous outcomes, with a median adjusted relative improvement of 21% (interquartile range 11% to 41%). There were eight trials (12 comparisons) in which the intervention included an EOV and was compared to another type of intervention, usually audit and feedback. Interventions that included EOVs appeared to be slightly superior to audit and feedback. Only six studies evaluated different types of visits in head-to-head comparisons. When individual visits were compared to group visits (three trials), the results were mixed. AUTHORS' CONCLUSIONS: EOVs alone or when combined with other interventions have effects on prescribing that are relatively consistent and small, but potentially important. Their effects on other types of professional performance vary from small to modest improvements, and it is not possible from this review to explain that variation.

After the era of plentiful antibiotics we are alarmed by the increasing number of antibiotic resistant strains. The genetic flexibility and adaptability of Escherichia coli to constantly changing environments allows to acquire a great number of antimicrobial resistance mechanisms. Commensal strains of E. coli as versatile residents of the lower intestine are also repeatedly challenged by antimicrobial pressures during the lifetime of their host. As a consequence, commensal strains acquire the respective resistance genes, and/or develop resistant mutants in order to survive and maintain microbial homeostasis in the lower intestinal tract. Thus, commensal E. coli strains are regarded as indicators of antimicrobial load on their hosts. This chapter provides a short historic background of the appearance and presumed origin and transfer of antimicrobial resistance genes in commensal intestinal E. coli of animals with comparative information on their pathogenic counterparts. The dynamics, development, and ways of evolution of resistance in the E. coli populations differ according to hosts, resistance mechanisms, and antimicrobial classes used. The most frequent tools of E. coli against a variety of antimicrobials are the efflux pumps and mobile resistance mechanisms carried by plasmids and/or other transferable elements. The emergence of hybrid plasmids (both resistance and virulence) among E. coli is of further concern. Co-existence and co-transfer of these "bad genes" in this huge and most versatile in vivo compartment may represent an increased public health risk in the future. Significance of multidrug resistant (MDR) commensal E. coli seem to be highest in the food animal industry, acting as reservoir for intra- and interspecific exchange and a source for spread of MDR determinants through contaminated food to humans. Thus, public health potential of MDR commensal E. coli of food animals can be a concern and needs monitoring and more molecular analysis in the future.

The ESC/ERS Guidelines represent the views of the ESC and ERS and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC and ERS are not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC/ERS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC/ERS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC/ERS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC/ERS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

Importance: Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250 people around the world of every race and ethnicity. The lack of general awareness of FH among the public and medical community has resulted in only 10% of the FH population being diagnosed and adequately treated. The World Health Organization recognized FH as a public health priority in 1998 during a consultation meeting in Geneva, Switzerland. The World Health Organization report highlighted 11 recommendations to address FH worldwide, from diagnosis and treatment to family screening and education. Research since the 1998 report has increased understanding and awareness of FH, particularly in specialty areas, such as cardiology and lipidology. However, in the past 20 years, there has been little progress in implementing the 11 recommendations to prevent premature atherosclerotic cardiovascular disease in an entire generation of families with FH. Observations: In 2018, the Familial Hypercholesterolemia Foundation and the World Heart Federation convened the international FH community to update the 11 recommendations. Two meetings were held: one at the 2018 FH Foundation Global Summit and the other during the 2018 World Congress of Cardiology and Cardiovascular Health. Each meeting served as a platform for the FH community to examine the original recommendations, assess the gaps, and provide commentary on the revised recommendations. The Global Call to Action on Familial Hypercholesterolemia thus represents individuals with FH, advocacy leaders, scientific experts, policy makers, and the original authors of the 1998 World Health Organization report. Attendees from 40 countries brought perspectives on FH from low-, middle-, and high-income regions. Tables listing country-specific government support for FH care, existing country-specific and international FH scientific statements and guidelines, country-specific and international FH registries, and known FH advocacy organizations around the world were created. Conclusions and Relevance: By adopting the 9 updated public policy recommendations created for this document, covering awareness; advocacy; screening, testing, and diagnosis; treatment; family-based care; registries; research; and cost and value, individual countries have the opportunity to prevent atherosclerotic heart disease in their citizens carrying a gene associated with FH and, likely, all those with severe hypercholesterolemia as well.

Illness and death from diseases caused by contaminated food are a constant threat to public health and a significant impediment to socio-economic development worldwide. To measure the global and regional burden of foodborne disease (FBD), the World Health Organization (WHO) established the Foodborne Disease Burden Epidemiology Reference Group (FERG), which here reports their first estimates of the incidence, mortality, and disease burden due to 31 foodborne hazards. We find that the global burden of FBD is comparable to those of the major infectious diseases, HIV/AIDS, malaria and tuberculosis. The most frequent causes of foodborne illness were diarrheal disease agents, particularly norovirus and Campylobacter spp. Diarrheal disease agents, especially non-typhoidal Salmonella enterica, were also responsible for the majority of deaths due to FBD. Other major causes of FBD deaths were Salmonella Typhi, Taenia solium and hepatitis A virus. The global burden of FBD caused by the 31 hazards in 2010 was 33 million Disability Adjusted Life Years (DALYs); children under five years old bore 40% of this burden. The 14 subregions, defined on the basis of child and adult mortality, had considerably different burdens of FBD, with the greatest falling on the subregions in Africa, followed by the subregions in South-East Asia and the Eastern Mediterranean D subregion. Some hazards, such as non-typhoidal S. enterica, were important causes of FBD in all regions of the world, whereas others, such as certain parasitic helminths, were highly localised. Thus, the burden of FBD is borne particularly by children under five years old-although they represent only 9% of the global population-and people living in low-income regions of the world. These estimates are conservative, i.e., underestimates rather than overestimates; further studies are needed to address the data gaps and limitations of the study. Nevertheless, all stakeholders can contribute to improvements in food safety throughout the food chain by incorporating these estimates into policy development at national and international levels.

BACKGROUND: Although the rising pandemic of obesity has received major attention in many countries, the effects of this attention on trends and the disease burden of obesity remain uncertain. METHODS: We analyzed data from 68.5 million persons to assess the trends in the prevalence of overweight and obesity among children and adults between 1980 and 2015. Using the Global Burden of Disease study data and methods, we also quantified the burden of disease related to high body-mass index (BMI), according to age, sex, cause, and BMI in 195 countries between 1990 and 2015. RESULTS: In 2015, a total of 107.7 million children and 603.7 million adults were obese. Since 1980, the prevalence of obesity has doubled in more than 70 countries and has continuously increased in most other countries. Although the prevalence of obesity among children has been lower than that among adults, the rate of increase in childhood obesity in many countries has been greater than the rate of increase in adult obesity. High BMI accounted for 4.0 million deaths globally, nearly 40% of which occurred in persons who were not obese. More than two thirds of deaths related to high BMI were due to cardiovascular disease. The disease burden related to high BMI has increased since 1990; however, the rate of this increase has been attenuated owing to decreases in underlying rates of death from cardiovascular disease. CONCLUSIONS: The rapid increase in the prevalence and disease burden of elevated BMI highlights the need for continued focus on surveillance of BMI and identification, implementation, and evaluation of evidence-based interventions to address this problem. (Funded by the Bill and Melinda Gates Foundation.).

Phlebotomine sandflies transmit pathogens that affect humans and animals worldwide. We review the roles of phlebotomines in the spreading of leishmaniases, sandfly fever, summer meningitis, vesicular stomatitis, Chandipura virus encephalitis and Carrión's disease. Among over 800 species of sandfly recorded, 98 are proven or suspected vectors of human leishmaniases; these include 42 Phlebotomus species in the Old World and 56 Lutzomyia species in the New World (all: Diptera: Psychodidae). Based on incrimination criteria, we provide an updated list of proven or suspected vector species by endemic country where data are available. Increases in sandfly diffusion and density resulting from increases in breeding sites and blood sources, and the interruption of vector control activities contribute to the spreading of leishmaniasis in the settings of human migration, deforestation, urbanization and conflict. In addition, climatic changes can be expected to affect the density and dispersion of sandflies. Phlebovirus infections and diseases are present in large areas of the Old World, especially in the Mediterranean subregion, in which virus diversity has proven to be higher than initially suspected. Vesiculovirus diseases are important to livestock and humans in the southeastern U.S.A. and Latin America, and represent emerging human threats in parts of India. Carrión's disease, formerly restricted to regions of elevated altitude in Peru, Ecuador and Colombia, has shown recent expansion to non-endemic areas of the Amazon basin.

BACKGROUND: Community participation is widely believed to be beneficial to the development, implementation and evaluation of health services. However, many challenges to successful and sustainable community involvement remain. Importantly, there is little evidence on the effect of community participation in terms of outcomes at both the community and individual level. Our systematic review seeks to examine the evidence on outcomes of community participation in high and upper-middle income countries. METHODS AND FINDINGS: This review was developed according to PRISMA guidelines. Eligible studies included those that involved the community, service users, consumers, households, patients, public and their representatives in the development, implementation, and evaluation of health services, policy or interventions. We searched the following databases from January 2000 to September 2016: Medline, Embase, Global Health, Scopus, and LILACs. We independently screened articles for inclusion, conducted data extraction, and assessed studies for risk of bias. No language restrictions were made. 27,232 records were identified, with 23,468 after removal of duplicates. Following titles and abstracts screening, 49 met the inclusion criteria for this review. A narrative synthesis of the findings was conducted. Outcomes were categorised as process outcomes, community outcomes, health outcomes, empowerment and stakeholder perspectives. Our review reports a breadth of evidence that community involvement has a positive impact on health, particularly when substantiated by strong organisational and community processes. This is in line with the notion that participatory approaches and positive outcomes including community empowerment and health improvements do not occur in a linear progression, but instead consists of complex processes influenced by an array of social and cultural factors. CONCLUSION: This review adds to the evidence base supporting the effectiveness of community participation in yielding positive outcomes at the organizational, community and individual level. TRIAL REGISTRATION: Prospero record number: CRD42016048244.

The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC and EAS is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC/EAS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC/EAS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC/EAS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

Tick-borne diseases represent major public and animal health issues worldwide. Ixodes ricinus, primarily associated with deciduous and mixed forests, is the principal vector of causative agents of viral, bacterial, and protozoan zoonotic diseases in Europe. Recently, abundant tick populations have been observed in European urban green areas, which are of public health relevance due to the exposure of humans and domesticated animals to potentially infected ticks. In urban habitats, small and medium-sized mammals, birds, companion animals (dogs and cats), and larger mammals (roe deer and wild boar) play a role in maintenance of tick populations and as reservoirs of tick-borne pathogens. Presence of ticks infected with tick-borne encephalitis virus and high prevalence of ticks infected with Borrelia burgdorferi s.l., causing Lyme borreliosis, have been reported from urbanized areas in Europe. Emerging pathogens, including bacteria of the order Rickettsiales (Anaplasma phagocytophilum, "Candidatus Neoehrlichia mikurensis," Rickettsia helvetica, and R. monacensis), Borrelia miyamotoi, and protozoans (Babesia divergens, B. venatorum, and B. microti) have also been detected in urban tick populations. Understanding the ecology of ticks and their associations with hosts in a European urbanized environment is crucial to quantify parameters necessary for risk pre-assessment and identification of public health strategies for control and prevention of tick-borne diseases.

BACKGROUND: Oculocutaneous albinism (OCA) is a genetically inherited autosomal recessive condition and OCA2, tyrosine-positive albinism, is the most prevalent type found throughout Africa. Due to the lack of melanin, people with albinism are more susceptible to the harmful effects of ultraviolet radiation exposure. This population must deal with issues such as photophobia, decreased visual acuity, extreme sun sensitivity and skin cancer. People with albinism also face social discrimination as a result of their difference in appearance. The World Health Organization is currently investigating the issues concerning this vulnerable population. METHODS: Systematic electronic search of articles in PubMed concerning albinism in Africa. Furthermore, a World Health Organization (WHO) pilot survey of albinism was drafted in English, French and Portuguese, and distributed to African countries through WHO African Regional Offices (AFRO) in an attempt to gather further information on albinism. RESULTS: Epidemiologic data on albinism, such as prevalence, were available for South Africa, Zimbabwe, Tanzania and Nigeria. Prevalences as high as 1 in 1,000 were reported for selected populations in Zimbabwe and other specific ethnic groups in Southern Africa. An overall estimate of albinism prevalences ranges from 1/5,000-1/15,000. In addition, both the literature review and the survey underscored the medical and social issues facing people with albinism. CONCLUSION: The estimated prevalence of albinism suggests the existence of tens of thousands of people living with albinism in Africa. This finding reiterates the need for increased awareness of and public health interventions for albinism in order to better address the medical, psychological and social needs of this vulnerable population.